Fine needle aspiration cytology in young women with breast cancer: diagnostic difficulties

References

• Seow A, Koh W P, Chia K S, Shi L M, Lee H P, Shanmugaratnam K. Trends in Cancer Incidence in Singapore 1968–2002. Singapore Cancer Registry Report No. 6. Singapore Cancer Registry, Singapore 2004
   Google Scholar
• Dawson A E, Mulford D K, Taylor A S, Logan-Young W. Breast carcinoma detection in women age 35 years and younger: mammography and diagnosis by fine needle aspiration cytology. Cancer 1998; 84: 163–168
   PubMed Web of Science ®Google Scholar
• Foxcroft L M, Evans E B, Porter A J. The diagnosis of breast cancer in women younger than 40. Breast 2004; 13: 297–306
   PubMed Web of Science ®Google Scholar
• Royal College of Pathologists Working Party on Breast Cancer Screening (Cytology Subcommittee). Guidelines for Cytology Reporting in Breast Cancer ScreeningRevised edition. NHS Screening Publications, Sheffield 1993
   Google Scholar
• Albain K S, Allred D C, Clark G M. Breast cancer outcome and predictors of outcome: are there age differentials?. J Natl Cancer Inst Monogr 1994; 16: 35–42
   PubMedGoogle Scholar
• Nixon A J, Neubreg D, Hayes D F, et al. Relationship of patient age to pathologic features of the tumour and the prognosis for patients with stage I or II breast cancer. J Clin Oncol 1994; 12: 888–894
   PubMed Web of Science ®Google Scholar
• Bonnier P, Romain S, Charpin C, et al. Age as a prognostic factor in breast cancer: relationship to pathologic and biologic features. Int J Cancer 1995; 62: 138–144
   PubMed Web of Science ®Google Scholar
• Bertheau P, Steinberg S M, Merino M J. cerbB2, p53, and nm23 gene product expression in breast cancer in young women: immunohistochemical analysis and clinicopathologic correlation. Hum Pathol 1998; 29: 323–329
   PubMed Web of Science ®Google Scholar
• Largent J A, Ziogas A, Anton-Culver H. Effect of reproductive factors on stage, grade and hormone receptor status in early-onset breast cancer. Breast Cancer Res 2005; 7: 541–554
   Web of Science ®Google Scholar
• Goldstein N S, Vicini F A, Kestin L L, Thomas M. Differences in the pathologic features of ductal carcinoma in situ of breast based on patient age. Cancer 2000; 88: 2553–2560
   PubMed Web of Science ®Google Scholar
• Vrieling C, Collette L, Fourquet A, et al. Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conservative therapy in young patients?. Eur J Cancer 2003; 39: 932–944
   PubMed Web of Science ®Google Scholar
• Zhou P, Recht A. Young age and outcome for women with early-stage invasive breast carcinoma. Cancer 2004; 101: 1264–1274
   PubMed Web of Science ®Google Scholar
• Rosen P P, Lesser M L, Kinne D W, Beattie E J. Breast carcinoma in women 35 years of age or younger. Ann Surg 1984; 199: 133–142
   PubMed Web of Science ®Google Scholar
• Max M H, Klamer T W. Breast cancer in 120 women under 35 years old. A 10-year community-wide survey. Ann Surg 1984; 50: 23–25
   Google Scholar
• Fernandopulle S M, Ang P CS, Tan P H. Breast carcinoma in women 35 years and younger: a pathological study. Pathology 2006; 38: 219–222
   PubMed Web of Science ®Google Scholar
• Gillett D, Kennedy C, Carmalt H. Breast cancer in young women. Aust NZ J Surg 1997; 67: 761–764
   PubMedGoogle Scholar
• Lu D, Masood S, Khalbuss W E, Bui M. A subset of breast invasive ductal carcinoma with distinctive cytomorphology, aggressive clinical behavior, and unique immunologic profiles. Cancer 2002; 96: 294–300
   PubMed Web of Science ®Google Scholar
• Selvarajan S, Wong K Y, Khoo K S, Bay B H, Tan P H. Overexpression of c-erbB2 correlates with nuclear morphometry and prognosis in breast carcinoma in Asian women. Pathology 2006; 38: 528–533
   PubMed Web of Science ®Google Scholar
• Chuwa W LE, Tan V HS, Tan P H, Yong W S, Ho G Y, Wong C Y. Treatment for ductal carcinoma in-situ in an Asian population: outcome and prognostic factors. A NZ J Surg 2008; 78: 42–48
   Web of Science ®Google Scholar
• Kim A, Lee J, Choi J S, Won N H, Koo B H. Fine needle aspiration cytology of the breast. Experience at an outpatient breast clinic. Acta Cytol 2000; 44: 361–367
   PubMed Web of Science ®Google Scholar
• Howat A J, Armstrong G R, Briggs W A, Nicholson C M, Stewart D J. Fine needle aspiration of palpable breast lumps: a 1-year audit using the Cytospin method. Cytopathology 1992; 3: 17–22
   PubMed Web of Science ®Google Scholar
• Hitchcock A, Hunt C M, Locker A, et al. A one year audit of fine needle aspiration cytology for the pre-operative diagnosis of breast disease. Cytopathology 1991; 2: 167–176
   PubMed Web of Science ®Google Scholar
• Chew I, Tan Y, Tan P H. Role of cytology in breast screening: results and long term follow-up of the Singapore Breast Screening Pilot Project. Cytopathology 2006; 17: 227–232
   PubMed Web of Science ®Google Scholar
• Neinstein L S. Breast disease in adolescents and young women. Pediatr Clin North Am 1999; 46: 607–629
   PubMed Web of Science ®Google Scholar
• Mitre B K, Kanbour A I, Mauser N. Fine needle aspiration biopsy of breast carcinoma in pregnancy and lactation. Acta Cytol 1997; 41: 1121–1130
   PubMed Web of Science ®Google Scholar
• Gupta R K, Naran S, Buchanan A, Fauck R, Simpson J. Fine-needle aspiration cytology of breast: its impact on surgical practice with an emphasis on the diagnosis of breast abnormalities in young women. Diagn Cytopathol 1988; 4: 206–209
   PubMed Web of Science ®Google Scholar
• Jayasinghe U W, Taylor R, Boyages J. Is age at diagnosis an independent factor for survival following breast cancer?. A NZ J Surg 2005; 75: 762–767
   Web of Science ®Google Scholar
• Litherland J C. Should fine needle aspiration cytology in breast assessment be abondoned?. Clin Radiol 2002; 2: 81–84
   Web of Science ®Google Scholar
• Jeffers M. Conversion to core biopsy in preoperative diagnosis of breast lesions: is it justified by results?. J Clin Pathol 2002; 55: 719–720
   PubMed Web of Science ®Google Scholar